Clinical Trial Update: SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 trial update for SOLUTION study of an oral liprotamase unit-matched therapy in non-porcine origin for cystic fibrosis with exocrine pancreatic insuffi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• liprotamase unit-matched therapy (non-porcine origin) (liprotamase unit-matched therapy (non-porcine origin))

Snippet

Sponsor: Anthera Pharmaceuticals | Conditions: Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-14